Zealand Pharma A/S | ZEAL - Beneficio Bruto En Ventas

Precio De Mercado
268.20
Cambio Diario
5.40 2.05%
Mensual
-31.25%
Anual
-54.19%
Q1 Expectativa
254.31




Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 49.21M 13.25M 2025-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Dianthus Therapeutics USD 396K 203K 2025-09
Ionis Pharmaceuticals USD 195M 40M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Moderna USD 226M 583M 2025-12
Organon & Co USD 854M 3M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 67.63M 15.62M 2025-03
Viatris USD 1.15B 223.6M 2025-12
Xeris Pharmaceuticals USD 63.38M 3.74M 2025-09